Abbott Laboratories (LON:0Q15)

Market Cap	173.82B
Revenue (ttm)	31.47B
Net Income (ttm)	10.17B
Shares Out	n/a
EPS (ttm)	5.82
PE Ratio	17.10
Forward PE	24.72
Dividend	1.79 (1.36%)
Ex-Dividend Date	Jul 15, 2025

Volume	11,464
Average Volume	3,711
Open	134.75
Previous Close	133.24
Day's Range	129.14 - 135.34
52-Week Range	105.68 - 141.41
Beta	0.66
RSI	55.48
Earnings Date	Oct 15, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0Q15

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD